Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 17 | 2024 | 2016 | 3.430 |
Why?
|
Papillomavirus Infections | 11 | 2023 | 1612 | 1.970 |
Why?
|
Uterine Cervical Dysplasia | 4 | 2024 | 384 | 1.720 |
Why?
|
Botswana | 23 | 2024 | 1040 | 1.580 |
Why?
|
Gynecology | 3 | 2019 | 528 | 0.940 |
Why?
|
Papillomavirus Vaccines | 4 | 2022 | 497 | 0.900 |
Why?
|
HIV Infections | 16 | 2024 | 17275 | 0.830 |
Why?
|
Alphapapillomavirus | 2 | 2022 | 219 | 0.780 |
Why?
|
Colposcopy | 3 | 2023 | 150 | 0.720 |
Why?
|
Early Detection of Cancer | 9 | 2024 | 3211 | 0.690 |
Why?
|
Human papillomavirus 18 | 1 | 2019 | 125 | 0.630 |
Why?
|
Human papillomavirus 16 | 1 | 2019 | 266 | 0.580 |
Why?
|
Genital Neoplasms, Female | 2 | 2021 | 533 | 0.560 |
Why?
|
Appointments and Schedules | 2 | 2021 | 441 | 0.520 |
Why?
|
Obstetrics | 2 | 2019 | 667 | 0.490 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2014 | 61 | 0.460 |
Why?
|
Babesiosis | 1 | 2014 | 92 | 0.430 |
Why?
|
Laboratories | 1 | 2015 | 460 | 0.400 |
Why?
|
Premature Birth | 5 | 2022 | 1771 | 0.330 |
Why?
|
HIV | 3 | 2023 | 1581 | 0.280 |
Why?
|
Papillomaviridae | 4 | 2022 | 1121 | 0.270 |
Why?
|
Malaria | 1 | 2015 | 1226 | 0.260 |
Why?
|
Curriculum | 1 | 2019 | 3717 | 0.260 |
Why?
|
Prevalence | 7 | 2024 | 15646 | 0.250 |
Why?
|
Triage | 2 | 2023 | 986 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3175 | 0.250 |
Why?
|
Maternal Mortality | 2 | 2024 | 300 | 0.240 |
Why?
|
Stillbirth | 4 | 2024 | 368 | 0.230 |
Why?
|
Acetic Acid | 1 | 2023 | 60 | 0.230 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2021 | 517 | 0.220 |
Why?
|
Referral and Consultation | 1 | 2015 | 3586 | 0.200 |
Why?
|
International Cooperation | 2 | 2019 | 1430 | 0.200 |
Why?
|
Internship and Residency | 2 | 2019 | 5865 | 0.200 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2024 | 2125 | 0.190 |
Why?
|
Female | 32 | 2024 | 390316 | 0.190 |
Why?
|
Infant, Small for Gestational Age | 3 | 2021 | 460 | 0.190 |
Why?
|
Pregnancy Outcome | 5 | 2024 | 2907 | 0.180 |
Why?
|
Adult | 19 | 2024 | 219916 | 0.170 |
Why?
|
Prospective Studies | 7 | 2024 | 54136 | 0.170 |
Why?
|
Faculty, Medical | 2 | 2019 | 1192 | 0.170 |
Why?
|
Self-Examination | 1 | 2019 | 71 | 0.170 |
Why?
|
Vulvar Neoplasms | 1 | 2021 | 263 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 176 | 0.160 |
Why?
|
Schools, Medical | 3 | 2019 | 877 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2021 | 583 | 0.140 |
Why?
|
Radiation Oncology | 1 | 2023 | 563 | 0.140 |
Why?
|
Humans | 36 | 2024 | 758381 | 0.140 |
Why?
|
Vaginal Smears | 1 | 2019 | 500 | 0.140 |
Why?
|
Angola | 1 | 2015 | 17 | 0.130 |
Why?
|
Organizational Objectives | 1 | 2018 | 426 | 0.130 |
Why?
|
Middle Aged | 13 | 2024 | 219560 | 0.130 |
Why?
|
Capacity Building | 1 | 2018 | 257 | 0.130 |
Why?
|
Models, Organizational | 1 | 2018 | 546 | 0.120 |
Why?
|
Organizational Culture | 1 | 2019 | 506 | 0.120 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11152 | 0.120 |
Why?
|
Specimen Handling | 1 | 2019 | 707 | 0.120 |
Why?
|
Program Development | 2 | 2018 | 1297 | 0.120 |
Why?
|
Self Care | 1 | 2019 | 794 | 0.110 |
Why?
|
Vagina | 1 | 2019 | 838 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 641 | 0.110 |
Why?
|
Professional Competence | 1 | 2015 | 431 | 0.100 |
Why?
|
National Health Programs | 1 | 2015 | 439 | 0.100 |
Why?
|
Hemolysis | 1 | 2014 | 423 | 0.100 |
Why?
|
Pregnancy | 8 | 2024 | 29742 | 0.100 |
Why?
|
Infant Mortality | 1 | 2016 | 757 | 0.100 |
Why?
|
Career Choice | 1 | 2017 | 752 | 0.090 |
Why?
|
Pilot Projects | 3 | 2019 | 8554 | 0.090 |
Why?
|
Morbidity | 1 | 2016 | 1754 | 0.090 |
Why?
|
Program Evaluation | 2 | 2017 | 2490 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 748 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 21273 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 1159 | 0.090 |
Why?
|
Medical Oncology | 1 | 2021 | 2312 | 0.080 |
Why?
|
Genotype | 1 | 2023 | 12945 | 0.080 |
Why?
|
Palliative Care | 1 | 2024 | 3570 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2942 | 0.080 |
Why?
|
Age Factors | 1 | 2024 | 18357 | 0.070 |
Why?
|
Survival Analysis | 2 | 2021 | 10112 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2751 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1725 | 0.070 |
Why?
|
Developing Countries | 1 | 2018 | 2866 | 0.070 |
Why?
|
Infant, Newborn | 5 | 2024 | 26182 | 0.060 |
Why?
|
Young Adult | 6 | 2024 | 58808 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3356 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25953 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5484 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8611 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39060 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4775 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7817 | 0.050 |
Why?
|
Mass Screening | 3 | 2022 | 5425 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3990 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 39873 | 0.040 |
Why?
|
Infant | 4 | 2024 | 36054 | 0.040 |
Why?
|
Personnel Loyalty | 1 | 2017 | 11 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 463 | 0.040 |
Why?
|
Women's Health Services | 1 | 2017 | 89 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.030 |
Why?
|
Adolescent | 3 | 2022 | 87888 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 80170 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 910 | 0.030 |
Why?
|
Africa | 1 | 2018 | 705 | 0.030 |
Why?
|
Labor, Induced | 1 | 2016 | 151 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 842 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22031 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2569 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1141 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2018 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6768 | 0.020 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 1780 | 0.020 |
Why?
|
United States | 1 | 2019 | 72140 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6493 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2017 | 2675 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22030 | 0.020 |
Why?
|
Child | 3 | 2022 | 79813 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2253 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 3056 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3082 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8823 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4504 | 0.010 |
Why?
|
Aged | 2 | 2024 | 168217 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15785 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41252 | 0.010 |
Why?
|
Male | 2 | 2019 | 358742 | 0.010 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_